10 January 2008
Can-Fite to collaborate with leading academic institutes on hepatitis C drug
BioPharma announced that cooperation agreements were signed with two worldwide leading research laboratories to promote the company s second drug pipeline, CF102. This cooperation will facilitate joint research to investigate the effect of CF102 on the hepatitis C virus (HCV).
03 January 2008
Silentium - Spatial Active Noise announced it has received $1.8 million in funding
Silentium, a leading Israeli innovator in Spatial Active Noise Control (ANC) technology, recently announced it has received $1.8 million in funding from Naor Group, and certain current investors. This initial funding marks the first step towards a $5 million round, the company plans to complete over the coming months.
1
(2 marks)